amylase 30000 UNT / lipase 6000 UNT / protease 19000 UNT Delayed Release Oral Capsule [Creon]
RxNorm concept 863836, branded drug (sbd). Prescribable name: CREON 6000 UNT / 30,000 UNT / 19,000 UNT Delayed Release Oral Capsule.
- RxCUI
- 863836
- Term type
- Branded drug (SBD)
- Status
- Active
curl https://api.healthcare.dev/v1/drugs/rxnorm/863836 \ -H "Authorization: Bearer $HDEV_API_KEY"
Concept
Ingredients and related concepts
Ingredients
Other names
Creon (amylases 30,000 UNT / endopeptidases 19,000 UNT / lipase 6000 UNT) Delayed Release Oral Capsule; Creon 6 (amylase 30,000 UNT / lipase 6000 UNT / protease 19,000 UNT) Delayed Release Oral Capsule; Creon 6,000 (lipase) Delayed Release Oral Capsule
Related concepts
- amylase 30000 UNT (SCDC, consists of)
- lipase 6000 UNT (SCDC, consists of)
- protease 19000 UNT (SCDC, consists of)
- amylase 30000 UNT / lipase 6000 UNT / protease 19000 UNT [Creon] (SBDC, consists of)
- Delayed Release Oral Capsule (DF, has dose form)
- Creon (BN, has ingredient)
- amylase 30000 UNT / lipase 6000 UNT / protease 19000 UNT Delayed Release Oral Capsule (SCD, tradename of)
Linked data
NDCs
NDC-11s RxNorm links to this concept; linked ones open their FDA product.
Use it
Look up 863836 from code or an agent
curl https://api.healthcare.dev/v1/drugs/rxnorm/863836 \ -H "Authorization: Bearer $HDEV_API_KEY"
Using the healthcare.dev MCP server, look up RxNorm concept 863836. Tell me its name and term type, its ingredients and related concepts, and the NDCs linked to it.
Source: U.S. National Library of Medicine, release 2026-10-05. No license required (Current Prescribable Content). Reference data, not medical advice.